関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Tromethamine hydrochloride | HCID 93573 | — |
| 反応物 | Magnesium Chloride | HCID 5360315 | — |
| 反応物 | (E)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid | HCID 6519333 | — |
| 生成物 | Prostaglandin D2 | HCID 448457 | — |
反応手順
To a binding-reaction solution (50 mM Tris/HCl, pH 7.4, 5 mM MgCl2) (0.2 ml) were added the human platelet membrane fraction (0.1 mg) and 5 nM [3H]PGD2 (115 Ci/mmol), and the mixture was reacted at 4° C. for 90 min. After the reaction, the mixture was filtered through a glass fiber filter paper and washed several times with cooled physiological saline, then the radioactivity retained on the filter paper was measured. The specific-binding ratio was calculated by subtracting the non-specific binding ratio which is the radioactivity similarly measured in the presence of 10 μM PGD2 from the total binding. The inhibitory activity of each compound was expressed as the concentration required for 50% inhibition (IC50), which was determined by depicting a substitution curve by plotting the binding ratio (%) in the presence of each compound, where the binding ratio in the absence of a test compound is 100%.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US07105564B1 |
|---|
| 出典データセット | uspto-grants-2006_09 |
|---|
| ORD ID | ord-1c45e1751b2f4900919518bf2c740f38 |
|---|
| 出典メモ | uspto-grants-2006_09 |
|---|